Man Group PLC Eagle Pharmaceuticals, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.26 - $6.51 $186,064 - $284,337	43,677 Added 70.97%	105,221 $551,000
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $115,472 - $379,337	24,940 Added 68.13%	61,544 $321,000
Q3 2023 Nov 14, 2023	BUY	$15.21 - $22.88 $556,746 - $837,499	36,604 New	36,604 $577,000
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $1.04 Million - $1.85 Million	-39,261 Reduced 36.37%	68,686 $1.82 Million
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $1.29 Million - $1.61 Million	-31,326 Reduced 22.49%	107,947 $4.8 Million
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $320,976 - $378,720	-7,200 Reduced 4.92%	139,273 $6.89 Million
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $581,914 - $722,630	12,700 Added 9.49%	146,473 $7.46 Million
Q3 2021 Nov 15, 2021	SELL	$43.79 - $55.78 $179,539 - $228,698	-4,100 Reduced 2.97%	133,773 $7.46 Million
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $176,928 - $213,600	-4,800 Reduced 3.36%	137,873 $5.9 Million
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $1.64 Million - $2.07 Million	40,553 Added 39.71%	142,673 $5.96 Million
Q4 2020 Feb 16, 2021	SELL	$41.72 - $51.34 $909,496 - $1.12 Million	-21,800 Reduced 17.59%	102,120 $4.76 Million
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $2.1 Million - $2.91 Million	56,833 Added 84.72%	123,920 $5.26 Million
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $69,400 - $88,307	-1,605 Reduced 2.34%	67,087 $3.22 Million
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $569,373 - $995,119	-16,566 Reduced 19.43%	68,692 $3.16 Million
Q4 2019 Feb 18, 2020	SELL	$54.32 - $64.31 $1.16 Million - $1.37 Million	-21,364 Reduced 20.04%	85,258 $5.12 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $1.58 Million - $1.78 Million	-29,613 Reduced 21.74%	106,622 $6.03 Million
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $5.63 Million - $7.06 Million	120,835 Added 784.64%	136,235 $7.59 Million
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $595,364 - $798,028	15,400 New	15,400 $778,000
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $175,117 - $323,004	-4,769 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $317,853 - $399,928	4,769 New	4,769 $331,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account